Cargando…

Iron depletion by iron chelators or ferroportin inhibits HIV-1 through the induction of HIF1α, p21 and IKBα and the inhibition of CDK9 and CDK2

Detalles Bibliográficos
Autores principales:	Kumari, Namita, Kovalsky, Dmytro, Breuer, Denitra, Niu, Xiaomei, Nekhai, Sergei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3847939/ http://dx.doi.org/10.1186/1742-4690-10-S1-P63

Ejemplares similares

Regulation of CDK9 Activity by Phosphorylation and Dephosphorylation
por: Nekhai, Sergei, et al.
Publicado: (2014)

CDK2 Regulates HIV-1 Transcription by Phosphorylation of CDK9 on Serine 90
por: Breuer, Denitra, et al.
Publicado: (2012)

Protein Phosphatase-1 Activates CDK9 by Dephosphorylating Ser175
por: Ammosova, Tatiana, et al.
Publicado: (2011)

Iron Transport through Ferroportin Is Induced by Intracellular Ascorbate and Involves IRP2 and HIF2α
por: Scheers, Nathalie, et al.
Publicado: (2014)

HIF2α activation and mitochondrial deficit due to iron chelation cause retinal atrophy
por: Kong, Yang, et al.
Publicado: (2023)

Hepcidin induces HIV-1 transcription inhibited by ferroportin
por: Xu, Min, et al.
Publicado: (2010)

Quercetin Inhibits Intestinal Iron Absorption and Ferroportin Transporter Expression In Vivo and In Vitro
por: Lesjak, Marija, et al.
Publicado: (2014)

Therapeutic Potential of Iron Chelating Therapy: Modification of Disease by Iron Depletion
por: Hershko, Chaim, et al.
Publicado: (1994)

CDK5RAP3 inhibits angiogenesis in gastric neuroendocrine carcinoma by modulating AKT/HIF-1α/VEGFA signaling
por: Lin, Jian-Xian, et al.
Publicado: (2019)

Ferroportin depletes iron needed for cell cycle progression in head and neck squamous cell carcinoma
por: Belvin, Benjamin Ross, et al.
Publicado: (2023)

Therapeutic potential of induced iron depletion using iron chelators in Covid-19
por: Poonkuzhi Naseef, Punnoth, et al.
Publicado: (2022)

Iron Availability in Tissue Microenvironment: The Key Role of Ferroportin
por: Gammella, Elena, et al.
Publicado: (2021)

Hepcidin-Ferroportin Interaction Controls Systemic Iron Homeostasis
por: Nemeth, Elizabeta, et al.
Publicado: (2021)

Objectives and Methods of Iron Chelation Therapy
por: Hershko, C., et al.
Publicado: (2003)

Multiple CDK inhibitor dinaciclib suppresses neuroblastoma growth via inhibiting CDK2 and CDK9 activity
por: Chen, Zhenghu, et al.
Publicado: (2016)

Adherence to Iron Chelation Therapy and Its Determinants
por: Sidhu, Sukhmani, et al.
Publicado: (2021)

Iron- and Hepcidin-Independent Downregulation of the Iron Exporter Ferroportin in Macrophages during Salmonella Infection
por: Willemetz, Alexandra, et al.
Publicado: (2017)

Differences in the Conformational Energy Landscape of CDK1 and CDK2 Suggest a Mechanism for Achieving Selective CDK Inhibition
por: Wood, Daniel J., et al.
Publicado: (2019)

Structure of hepcidin-bound ferroportin reveals iron homeostatic mechanisms
por: Billesbølle, Christian B., et al.
Publicado: (2020)

The Oral Ferroportin Inhibitor VIT-2763 Improves Erythropoiesis without Interfering with Iron Chelation Therapy in a Mouse Model of β-Thalassemia
por: Nyffenegger, Naja, et al.
Publicado: (2021)

Inhibition of autoimmune neuropathological process by treatment with an iron-chelating agent
Publicado: (1984)

The Fungal Iron Chelator Desferricoprogen Inhibits Atherosclerotic Plaque Formation
por: Potor, László, et al.
Publicado: (2020)

Iron Chelator Transmetalative Approach to Inhibit Human Ribonucleotide Reductase
por: Gaur, Kavita, et al.
Publicado: (2021)

The transcriptome of CDK4/6 inhibition
por: Knudsen, Erik S., et al.
Publicado: (2017)

Iron Chelators in Treatment of Iron Overload
por: Entezari, Sarina, et al.
Publicado: (2022)

Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion
por: Zarei, Mahsa, et al.
Publicado: (2019)

Anti-cancer efficacy including Rb-deficient tumors and VHL-independent HIF1α proteasomal destabilization by dual targeting of CDK1 or CDK4/6 and HSP90
por: Zhao, Shuai, et al.
Publicado: (2021)

HIV-1 Resistant CDK2-Knockdown Macrophage-Like Cells Generated from 293T Cell-Derived Human Induced Pluripotent Stem Cells
por: Jerebtsova, Marina, et al.
Publicado: (2012)

Iron-Responsive miR-485-3p Regulates Cellular Iron Homeostasis by Targeting Ferroportin
por: Sangokoya, Carolyn, et al.
Publicado: (2013)

Reduced iron export associated with hepcidin resistance can explain the iron overload spectrum in ferroportin disease
por: Viveiros, André, et al.
Publicado: (2020)

The kidney hepcidin/ferroportin axis controls iron reabsorption and determines the magnitude of kidney and systemic iron overload
por: Mohammad, Goran, et al.
Publicado: (2021)

Repression of the iron exporter ferroportin may contribute to hepatocyte iron overload in individuals with type 2 diabetes
por: Qiu, Ruiyue, et al.
Publicado: (2022)

The role of vitamin D in regulating the iron-hepcidin-ferroportin axis in monocytes
por: Zughaier, Susu M., et al.
Publicado: (2014)

Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13
por: Zeng, Mei, et al.
Publicado: (2018)

Pre-RC Protein MCM7 depletion promotes mitotic exit by Inhibiting CDK1 activity
por: Zheng, Dianpeng, et al.
Publicado: (2017)

Unexpected Outcomes of CDK4/6 Inhibition
por: Choi, Yoon Jong, et al.
Publicado: (2013)

ATRT-20. CDK7 INHIBITION IN AT/RT
por: Morin, Andrew, et al.
Publicado: (2020)

ATRT-24. CDK7 Inhibition in AT/RT
por: Morin, Andrew, et al.
Publicado: (2022)

Inhibition of Cdk8/Cdk19 Activity Promotes Treg Cell Differentiation and Suppresses Autoimmune Diseases
por: Guo, Zengli, et al.
Publicado: (2019)

Inhibition of the CDK2 and Cyclin A complex leads to autophagic degradation of CDK2 in cancer cells
por: Zhang, Jiawei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kstf58k4vufsgdodv1bg2qm615